SEK 143.2
Key Takeaways
Risk factor
Vulnerable to price shocks
Profitability factor
Strong margins and returns
About
Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued
Target Price
The average target price of BIOT.ST is 143 and suggests 0% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
